Article Details
Retrieved on: 2021-04-15 16:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Following Roche's announcement of new 2-year data from Part 2 of FIREFISH, a Phase II/III global study evaluating Evrysdi (risdiplam) in infants aged ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here